)
Editas Medicine (EDIT) investor relations material
Editas Medicine AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order by the Chair, held in an all-virtual format to ensure equal participation rights for all stockholders.
Introductions included board members, senior management, independent auditor, and Inspector of Election.
Rules of conduct and confirmation of proper notice to stockholders were addressed.
Board and executive committee updates
Attendance included all directors, CEO, CFO, Chief Scientific Officer, General Counsel, and other senior leaders.
Shareholder proposals
Three proposals: election of two Class I directors, advisory vote on executive compensation, and ratification of the independent auditor.
- Pivoting to in vivo gene editing, with proof of concept achieved and cash runway to Q2 2027.EDIT
Strategy Update9 Jul 2026 - In vivo gene editing and reni-cel partnership drive strategic focus, with strong financial runway.EDIT
Stifel 2024 Healthcare Conference9 Jul 2026 - Reniz-cel shows strong efficacy as the company advances in vivo editing and IP monetization strategies.EDIT
Morgan Stanley 22nd Annual Global Healthcare Conference8 Jul 2026 - Q2 net loss widened to $67.6M as R&D spending surged; cash runway extends into 2026.EDIT
Q2 20248 Jul 2026 - CRISPR-based LDLR upregulation shows 90% LDL reduction, with human trials set for 2026.EDIT
Evercore ISI 8th Annual HealthCONx Conference30 Jun 2026 - EDIT-401 shows durable 90% LDL and Lp(a) reduction, with clinical trials starting in 2024.EDIT
Jefferies Global Healthcare Conference 20264 Jun 2026 - EDIT-401 achieved >90% LDL-C reduction preclinically, targeting major unmet needs in hyperlipidemia.EDIT
Corporate presentation27 May 2026 - Net loss narrowed to $25M as EDIT-401 advanced and cash runway extends into Q3 2027.EDIT
Q1 20265 May 2026 - Proxy covers director elections, pay, auditor change, and strong governance with ESG focus.EDIT
Proxy filing28 Apr 2026
Next Editas Medicine earnings date
Next Editas Medicine earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)